Skip to main content

Editors' pick

04-21-2017 | Lymphoma | Feature | Article

Lymphoma in practice: Professor Anas Younes speaks to medwireNews

Professor Anas Younes tells medwireNews about the current issues in lymphoma practice, both for the clinician and patients.

06-17-2016 | Colorectal cancer | Article

Deficient mismatch repair and the role of immunotherapy in metastatic colorectal cancer

This review discusses the immunogenicity of a subgroup of colorectal tumours, the microsatellite instability immune subgroup, and the role that immunotherapy may play in the treatment of these malignancies.

03-14-2017 | Leukemia | Editorial | Article

FMS-like tyrosine kinase 3 (FLT3)-inhibition in FLT3 mutated acute myeloid leukemia: A promising approach

Advisory Board Member Xavier Thomas discusses the potential of FLT3 inhibitors for the treatment of acute myeloid leukemia.

Latest from across the site

05-26-2017 | Non-small cell lung cancer | News

Alectinib outperforms crizotinib in Japanese patients with ALK-rearranged NSCLC

Among Japanese patients with advanced non-small-cell lung cancer harboring anaplastic lymphoma kinase translocations, progression-free survival is significantly longer with alectinib than crizotinib, shows a head-to-head phase III trial.


Lancet 2017; Advance online publication

05-25-2017 | FDA | Drug approval | News


Pembrolizumab receives agnostic approval for MSI-H/dMMR tumors

Click through to read more on these announcements

05-24-2017 | Ovarian cancer | News

Bevacizumab benefits ovarian cancer patients irrespective of timing

Patients with platinum-resistant ovarian cancer gain significant survival benefit from treatment with bevacizumab, regardless of whether its given with or after chemotherapy, an exploratory analysis of AURELIA study data show.


Ann Oncol 2017; Advance online publication

05-23-2017 | Thyroid cancer | News

Recommendation against routine thyroid cancer screening retained

In a statement published in JAMA, the US Preventive Services Task Force upholds its 1996 recommendation against screening for thyroid cancer among asymptomatic adults.


JAMA 2017; 317: 1840–1841, 1882–1887, 1888–1903, JAMA Otolaryngol Head Neck Surg 2017; Advance online publication, JAMA Surg 2017; Advance online publication

05-22-2017 | Pancreatic cancer | News

Targeting mitochondrial metabolism shows promise in pancreatic cancer

Researchers report promising results from a phase I trial evaluating CPI-613, which targets mitochondrial metabolism, in combination with modified FOLFIRINOX chemotherapy for the treatment of metastatic pancreatic cancer.


Lancet Oncol 2017; Advance online publication

05-19-2017 | Breast cancer | News

In other news

Here we report on osteoporosis therapy in breast cancer patients, the feasibility of an alternative formulation of rituximab in follicular lymphoma, the effects of extended use of anamorelin on lung cancer-related cachexia, and the 3-year results of the COMBI-d trial.

Meet our Advisory Board

image credits